Oramed to Present at Cantor Fitzgerald Virtual Global Healthcare Conference

NEW YORK, Sept. 23, 2021 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP), (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that Chief Executive Officer Nadav Kidron will present a company overview at the Cantor Fitzgerald Global Healthcare Conference, held virtually this year from September 27-30, 2021. […]